login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
GUARDANT HEALTH INC (GH) Stock News
USA
- NASDAQ:GH -
US40131M1099
-
Common Stock
57.19
USD
+1.79 (+3.23%)
Last: 9/17/2025, 8:00:01 PM
56.5146
USD
-0.68 (-1.18%)
After Hours:
9/17/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GH Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Guardant Health, Inc.
Alex M. Azar II Joins Guardant Health Board of Directors
7 days ago - By: Guardant Health, Inc.
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
2 months ago - By: Benzinga
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings
10 days ago - By: Guardant Health, Inc.
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
14 days ago - By: Zacks Investment Research
- Mentions:
EXAS
TEM
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
14 days ago - By: Investor's Business Daily
- Mentions:
EXAS
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run
2 months ago - By: The Motley Fool
Guardant Health (GH) Q2 Revenue Up 31%
2 months ago - By: Benzinga
- Mentions:
ALL
ZIMV
NEU
LRCX
...
Earnings Scheduled For July 30, 2025
14 days ago - By: Guardant Health, Inc.
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
20 days ago - By: Guardant Health, Inc.
Guardant Health to Host Investor Day on September 24, 2025
22 days ago - By: Guardant Health, Inc.
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
a month ago - By: Guardant Health, Inc.
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Zacks Investment Research
- Mentions:
TMO
ILMN
EXAS
TMO Receives FDA Approval for Oncomine Dx Target Test
a month ago - By: Zacks Investment Research
- Mentions:
EXAS
TEM
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
a month ago - By: Guardant Health, Inc.
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
2 months ago - By: Guardant Health, Inc.
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
2 months ago - By: Guardant Health, Inc.
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
2 months ago - By: Guardant Health, Inc.
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
2 months ago - By: Guardant Health, Inc.
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
Please enable JavaScript to continue using this application.